Last reviewed · How we verify
NCT05641389
Improving Remote Breathalyzer Procedures Used by Clinicians and Researchers to Remotely Monitor Alcohol Use
trial testing Monitoring in Alcohol Monitoring in 60 participants. Currently enrolling.
31 July 2024
Quick facts
| Lead sponsor | University of North Texas, Denton, TX |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 1 August 2022 |
| Primary completion | 31 July 2024 |
| Estimated completion | 31 July 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Monitoring
Conditions studied
- Alcohol Monitoring — all drugs for Alcohol Monitoring →
- Alcohol Use Disorder — all drugs for Alcohol Use Disorder →
Sponsor
University of North Texas, Denton, TX
Who can join
21 and older, any sex, with Alcohol Monitoring or Alcohol Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Remote breath alcohol monitors have been increasingly adopted for use in clinical, research and forensic settings to monitor alcohol use because they offer several key advantages over other available monitoring methods. However, it remains unknown if remote breathalyzers reliably detect alcohol use because there is up to a 10-hour window of time when breath samples are not obtained (to allow for sleeping). Additionally, the investigators will examine whether a supplemental measurement of a blood alcohol use biomarker (phosphatidylethanol) can confirm abstinence and/or detect individuals engaging in late-evening drinking to avoid the negative consequences associated with detected alcohol use.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05641389
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Monitoring
Trials testing the same drug.
- NCT07288034 — Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatmen · Phase 2 · recruiting
- NCT07095140 — Studying the Effects of Nicotine Concentration and Flavor on Alcohol Use in Young Adults · NA · recruiting
- NCT07091864 — Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma · NA · recruiting
- NCT07138326 — Impact on the Absorption of Drugs in Ostomy Patients · recruiting
- NCT06917326 — Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates · NA · completed
Other University of North Texas, Denton, TX trials
Trials by the same sponsor.
- NCT06506097 — Family-school Partnership Intervention for Early Childhood Education · NA · recruiting
- NCT05523453 — Examining Effects of a Therapeutic Focus on Positive Memories on Post-Trauma Health · NA · completed
- NCT05712408 — Examining the Impact of an Online, Non-restrictive Diet Among Persons With Multiple Sclerosis · NA · completed
- NCT05571605 — Cerebrovascular Dysregulation in Chronic Kidney Disease · NA · completed
- NCT05837611 — Deposit Contracts to Increase Accessibility of a Contingency Management Intervention to Reduce Problematic Drinking · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05641389 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of North Texas, Denton, TX
- Last refreshed: 10 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05641389.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing